ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Dose-ranging Study of the Efficacy of ESN364 in Postmenopausal Women Suffering Vasomotor Symptoms (Hot Flashes)

ClinicalTrials.gov ID: NCT03192176

Public ClinicalTrials.gov record NCT03192176. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 2:38 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging, Phase 2b Study to Investigate the Efficacy of ESN364 in Postmenopausal Women Suffering From Vasomotor Symptoms (Hot Flashes)

Study identification

NCT ID
NCT03192176
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
356 participants

Conditions and interventions

Interventions

  • Fezolinetant Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years to 65 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 18, 2017
Primary completion
Sep 18, 2018
Completion
Sep 18, 2018
Last update posted
Nov 25, 2024

2017 – 2018

United States locations

U.S. sites
51
U.S. states
24
U.S. cities
49
Facility City State ZIP Site status
Research Site Anniston Alabama 36207
Research Site Birmingham Alabama 35205
Research Site Phoenix Arizona 85023
Research Site Los Angeles California 90057
Research Site Oceanside California 92056
Research Site Panorama City California 91402
Research Site 052 Sacramento California 95821
Research Site 058 Sacramento California 95821
Research Site San Diego California 92114
Research Site Thousand Oaks California 91360
Research Site Valley Village California 91607
Research Site Denver Colorado 80209
Research Site Milford Connecticut 06460
Research Site Crystal River Florida 34429
Research Site DeLand Florida 32720
Research Site Jupiter Florida 33458
Research Site Lake Worth Florida 33461
Research Site Miami Florida 33144
Research Site Ormond Beach Florida 32174
Research Site Port Saint Lucie Florida 34952
Research Site Atlanta Georgia 30312
Research Site Norcross Georgia 30092
Research Site Meridian Idaho 83642
Research Site Champaign Illinois 61820
Research Site Marrero Louisiana 70072
Research Site Elkridge Maryland 21075
Research Site Watertown Massachusetts 02472
Research Site Lincoln Nebraska 68510
Research Site Norfolk Nebraska 68701
Research Site Las Vegas Nevada 89123
Research Site New York New York 10032
Research Site Williamsville New York 14221
Research Site Cincinnati Ohio 45267
Research Site Cleveland Ohio 44122
Research Site Columbus Ohio 43210
Research Site Columbus Ohio 43213
Research Site Oklahoma City Oklahoma 73112
Research Site Philadelphia Pennsylvania 19140
Research Site Mt. Pleasant South Carolina 29464
Research Site Clarksville Tennessee 37040
Research Site Kingsport Tennessee 37660
Research Site Houston Texas 77058
Research Site Hurst Texas 76054
Research Site Lampasas Texas 76550
Research Site Plano Texas 75093
Research Site San Antonio Texas 78229
Research Site Riverton Utah 84065
Research Site Charlottesville Virginia 22911
Research Site Vienna Virginia 22182
Research Site Seattle Washington 98105
Research Site Spokane Washington 99207

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03192176, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 25, 2024 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03192176 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →